Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2021-09-09 00:00:00 ET · period of report 2021-09-07 · accession 0001209191-21-055402 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-09 | 2021-09-07 | KYNB | Graham Juan | CFO | A - Grant | $0.00 | +35.0K | 36.4K | +2,500% | $0 |
| D | 2021-09-09 | 2021-09-07 | KYNB | Graham Juan | CFO | A - Grant | $0.00 | +196.0K | 196.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-07 | A | A | 35,000 | $0.00 | 36,400 | D | — | — | (F1) Represents that grant of restricted stock units. Twenty-five percent of the restricted stock units vest on September 7, 2022, and the remainder vests in equal amount quarterly thereafter for the following three years. |
| 2 | Derivative | Stock Option (Right to Buy) | 2021-09-07 | A | A | 196,000 | $0.00 | 196,000 | D | $12.41 · — to 2031-09-07 | 196,000 Common Stock | (F2) Twenty-five percent of the shares subject to the option vests on September 7, 2022, and the remainder vests in equal amount quarterly thereafter for the following three years. |